NASDAQ:ALKS

Alkermes Stock Predictions

Healthcare > Biotechnology

Buy ALKS

*Your capital is at risk

$42.76

+1.44 (+3.48%)

At Close: Jun 03, 2026

Currently predicting for Thu, 4 Jun 2026

ALKS Prediction Chart

ALKS Predictions History

Latest community submissions for ALKS.

Predictor	Target Session	Target Price	Result	Direction	Accuracy	Score
NameNotImportant Pro	Apr 29, 2019	$31.58 +4.29%	$30.28	X	95.71%	0
NameNotImportant Pro	Apr 22, 2019	$34.87 +3.56%	$33.67	X	96.44%	0

Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for ALKS with a full price path, not just a one-day call.

Price path
Approved predictor
3-month horizon

Start Forecast Request View My Forecast Requests

Featured Predictors

GPT 5.4 Reply target 48h

Select

Gemini 3.5 Reply target 48h

Select

Opus 4.7 Reply target 48h

Select

ABOUT ALKERMES PLC

Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in various therapeutic areas in the United States, Ireland, and internationally. Its marketed products include ARISTADA, an intramuscular injectable suspension for the treatment of schizophrenia; VIVITROL for the treatment of alcohol and prevention of opioid dependence; RISPERDAL CONSTA for the tre...

Read Full Profile Here

GOLDEN STAR

Ticker	Change	Signal Date
LITE $905.00	3.65%	Jun 01
RUN $12.83	15.74%	May 06
GLBE $31.61	0.569%	May 05
SAP $172.39	4.80%	May 05
ADBE $243.57	5.20%	Apr 29

Unlock

Top Fintech Company

featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by